Cargando…

Temozolomide for the treatment of metastatic melanoma

QUESTIONS: What is the role of single-agent temozolomide in the treatment of patients with metastatic melanoma? In comparison with single-agent temozolomide, does the addition of interferon-α to temozolomide improve disease-free survival, overall survival, or response rates? In comparison with singl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quirbt, I., Verma, S., Petrella, T., Bak, K., Charette, M.
Formato:	Texto
Lenguaje:	English
Publicado:	Multimed Inc. 2007
Materias:	Practice Guideline Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1891190/ https://www.ncbi.nlm.nih.gov/pubmed/17576461

Ejemplares similares

Single-agent interleukin-2 in the treatment of metastatic melanoma
por: Petrella, T., et al.
Publicado: (2007)

Biochemotherapy for the treatment of metastatic malignant melanoma: a clinical practice guideline
por: Verma, S., et al.
Publicado: (2008)

The role of her2-targeted therapies in women with her2-overexpressing metastatic breast cancer
por: Dent, S., et al.
Publicado: (2009)

Dose-intensive chemotherapy with growth factor or autologous bone marrow or stem-cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a clinical practice guideline
por: Verma, S., et al.
Publicado: (2008)

Optimal use of taxanes in metastatic breast cancer
por: King, K.M., et al.
Publicado: (2009)

The role of neoadjuvant her2-targeted therapies in her2-overexpressing breast cancers
por: Lemieux, J., et al.
Publicado: (2009)

The role of the epidermal growth factor receptor tyrosine kinase inhibitors as therapy for advanced, metastatic, and recurrent non-small-cell lung cancer: a Canadian national consensus statement
por: Ellis, P.M., et al.
Publicado: (2009)

Treatment of depression in cancer patients
por: Rodin, G., et al.
Publicado: (2007)

Ifosfamide-based combination chemotherapy in advanced soft-tissue sarcoma: a practice guideline
por: Verma, S., et al.
Publicado: (2007)

Cardiac management during adjuvant trastuzumab therapy: recommendations of the Canadian Trastuzumab Working Group
por: Mackey, J.R., et al.
Publicado: (2008)

Gliadel wafers in the treatment of malignant glioma: a systematic review
por: Perry, J., et al.
Publicado: (2007)

Canadian supportive care recommendations for the management of neutropenia in patients with cancer
por: Kouroukis, C.T., et al.
Publicado: (2008)

A framework for the organization and delivery of systemic treatment
por: Vandenberg, T., et al.
Publicado: (2009)

Optimal chemotherapy treatment for women with recurrent ovarian cancer
por: Fung-Kee-Fung, M., et al.
Publicado: (2007)

Canadian recommendations for the treatment of glioblastoma multiforme
por: Mason, W.P., et al.
Publicado: (2007)

Management of skin rash during egfr-targeted monoclonal antibody treatment for gastrointestinal malignancies: Canadian recommendations
por: Melosky, B., et al.
Publicado: (2009)

Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first- and second-line treatment of advanced colorectal cancer
por: Jonker, D., et al.
Publicado: (2006)

Cost effectiveness of tac versus fac in adjuvant treatment of node-positive breast cancer
por: Mittmann, N., et al.
Publicado: (2010)

(131)I–Tositumomab in lymphoma
por: Cheung, M.C., et al.
Publicado: (2009)

Adjuvant hormonal therapy for stage I endometrial cancer
por: Gien, L., et al.
Publicado: (2008)

Alemtuzumab in chronic lymphocytic leukemia
por: Fraser, G., et al.
Publicado: (2007)

Bortezomib in multiple myeloma and lymphoma: a systematic review and clinical practice guideline
por: Reece, D., et al.
Publicado: (2006)

Management of single brain metastasis: a practice guideline
por: Mintz, A., et al.
Publicado: (2007)

The use of prophylactic anticonvulsants in patients with brain tumours—a systematic review
por: Perry, J., et al.
Publicado: (2006)

Cancer antigen 125 in ovarian cancer surveillance: a decision analysis model
por: Hopkins, M.L., et al.
Publicado: (2007)

Clinician–patient communication: evidence-based recommendations to guide practice in cancer
por: Rodin, G., et al.
Publicado: (2009)

Canadian supportive care recommendations for the management of anemia in patients with cancer
por: Mikhael, J., et al.
Publicado: (2007)

Updated recommendations from the Canadian National Consensus Meeting on HER2/neu testing in breast cancer
por: Hanna, W., et al.
Publicado: (2007)

Guidelines for the diagnosis and management of carcinoid tumours. Part 1: The gastrointestinal tract. A statement from a Canadian National Carcinoid Expert Group
por: Maroun, J., et al.
Publicado: (2006)

Preparation with recombinant humanized thyroid-stimulating hormone before radioiodine ablation after thyroidectomy: a systematic review
por: Yoo, J., et al.
Publicado: (2009)

Colorectal Cancer Association of Canada consensus meeting: raising the standards of care for early-stage rectal cancer
Publicado: (2009)

Summary version of the Standards, Options and Recommendations for the use of analgesia for the treatment of nociceptive pain in adults with cancer (update 2002)
por: Krakowski, I, et al.
Publicado: (2003)

Chinese guidelines for diagnosis and treatment of melanoma 2018 (English version)
Publicado: (2019)

Guidelines for the diagnosis and treatment of follicular lymphoma in China
Publicado: (2013)

Multidisciplinary, three-dimensional and individualized comprehensive treatment for severe/critical COVID-19()()
Publicado: (2020)

Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms
por: Yamagami, Wataru, et al.
Publicado: (2019)

Japanese Practice Guidelines for Fecal Incontinence Part 2-Examination and Conservative Treatment for Fecal Incontinence- English Version
por: Maeda, Kotaro, et al.
Publicado: (2021)

Head and neck melanoma (excluding ocular melanoma): United Kingdom National Multidisciplinary Guidelines
por: Ahmed, O A, et al.
Publicado: (2016)

The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer
por: Tokunaga, Hideki, et al.
Publicado: (2021)

Japanese Practice Guidelines for Fecal Incontinence Part 3 -Surgical Treatment for Fecal Incontinence, Fecal Incontinence in a Special Conditions- English Version
por: Maeda, Kotaro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rdqtukfc7it7b42135aritldk6